KRYS · Krystal Biotech, Inc. · Executive Compensation
$305.23
-0.45 (-0.15%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$9.05B
Shares
29.63M
Volume · Nov 13
110.29K
Avg daily vol (3M)
280.28K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Krish S. Krishnan | Chair and Chief Executive Officer | $10,442,485 |
| Suma M. Krishnan | President, R&D | $6,948,401 |
| Kathryn Romano | Chief Accounting Officer | $2,258,697 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Krish S. Krishnan | Chair and Chief Executive Officer | $15,603,652 |
| Suma M. Krishnan | President, R&D | $8,243,817 |
| Kathryn Romano | Chief Accounting Officer | $3,053,517 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Krish S. Krishnan | Chair and Chief Executive Officer | $6,223,894 |
| Suma M. Krishnan | President, R&D | $3,835,481 |
| Kathryn Romano | Chief Accounting Officer | $2,574,971 |
| Andrew C. Orth | Chief Commercial Officer | $2,264,328 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Krish S. Krishnan | Chair and Chief Executive Officer | $3,256,467 |
| Suma M. Krishnan | President, R&D | $2,979,559 |
| Andrew C. Orth | Chief Commercial Officer | $2,850,169 |
| Kathryn Romano | Chief Accounting Officer | $2,718,503 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Andrew C. Orth | Chief Commercial Officer | $9,003,058 |
| Krish S. Krishnan | Chair and Chief Executive Officer | $7,350,978 |
| Suma M. Krishnan | President, R&D | $5,123,121 |
| Kathryn Romano | Chief Accounting Officer | $3,499,102 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kathryn Romano | Chief Accounting Officer | $1,993,559 |
| Krish S. Krishnan | Chair and Chief Executive Officer | $763,773 |
| Suma M. Krishnan | President, R&D | $602,976 |
| Andrew C. Orth | Chief Commercial Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Antony A. Riley | Chief Financial Officer | $660,844 |
| Krish S. Krishnan | Chairman and Chief Executive Officer | $365,725 |
| Suma M. Krishnan | Chief Operating Officer | $305,642 |
| Pooja Agarwal | Senior Vice President, Product Development | $259,583 |
| Kathryn Romano | Chief Accounting Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Krish S. Krishnan | Chairman and Chief Executive Officer | $704,994 |
| Suma M. Krishnan | Chief Operating Officer | $495,444 |
| Pooja Agarwal | Senior Vice President, Product Development | $440,958 |
| Antony A. Riley | Chief Financial Officer | $278,161 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kirti Ganorkar | Board of Directors | Resigned | 2025-12-23 |
| Andrew Orth | Chief Commercial Officer | Resigned | 2023-08-07 |
| Catherine Mazzacco | independent member of the Board | Appointed | 2023-03-06 |
Leadership
- Krish S. Krishnan CEO, Board Member
- Suma Krishnan COO, Board Member
- Suma M. Krishnan COO
- John C. Thomas General Counsel
- Kathryn Romano Chief Accounting Officer
- Christopher Mason Board Member
- Jing Marantz Board Member
Key facts
CIK
1711279
CUSIP
501147102
13F (30d)
365 filings
333 filers
Visit website
Investor relations